Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118226) titled 'Prospective, observational study on predicting immunotherapy efficacy in intrahepatic cholangiocarcinoma using deep learning-based virtual multiplex immunofluorescence score' on Feb. 3.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Shanghai Tenth People's Hospital Ethics Committee
Condition:
Intrahepatic Cholangiocarcinoma (ICC)
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-03
Target Sample Size: Case series:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=309090
Published by HT Digit...